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Abstract Only 
 
Utilising the Clinical Excellence Commission’s Performance Indicators for Quality 
Use of Medicines 
  
Like other aspects of health care, Quality Use of Medicine (QUM) can be considered in terms of 
structures, processes and outcomes. These components of QUM can be measured with 
performance indicators. This poster describes the Clinical Excellence Commissions (CEC) new 
performance indicators and their use in a warfarin practice improvement project. 
 
 Aim: To measure performance indicators in order to; Comprehensively audit warfarin 
therapy 
 Benchmarking current practices  
 Identify opportunities for practice improvement 
 Measure practice change  
 
Method: Auditing structures, processes, and outcomes requires different tools and methods. For 
this project, the following tools were utilised;  
The CEC Medication Safety Self Assessment for Antithrombotic Therapy in Australian 
Hospitals tool (MSSA-AT) was selected to provide qualitative data on hospital structure, culture, 
systems, policies, procedures and activities.  
The CEC and NSW TAG Indicators for Quality Use of Medicines in Australian Hospitals were 
used to review processes. These indicators provided quantitative data regarding the impact and 
effectiveness of systems, policies and procedures.  
Indicators from Australia Council of Health Care Standards (ACHS) provided quantitative data 
related to patient outcomes.  
 
Results: Together, the tools provided a comprehensive evaluation of warfarin therapy at St 
Vincents Private Hospital. The MSSA-AT provided a baseline measure of performance, a 
benchmark of practices, and numerous areas for practice improvement. The CEC’s process 
indicators provided a picture of current practices. This data, when benchmarked, identified 
strengths and opportunities and the ongoing measurement of these indicators will provide 
ongoing evidence of practice change. The ACHS outcomes date provided evidence that, although 
room for improvement, outcomes remained comparable with national data. 
 
Conclusion: Using performance indicators enabled a comprehensive review of clinical practice 
by providing information from a variety of sources about different aspects of therapy.  This 
information can then facilitate the practice improvement process. 
 
